top of page

​Meet C3 2025
C3 annual conference
Toronto April 4-6, 2025

The Cholangiocarcinoma Collaborative is pleased to invite you to the annual C3 meeting, MEET C3 2025, dedicated to advancing knowledge and collaboration within this challenging field.

Over three days, patients, physicians, clinicians, researchers, patient partners, and advocates will gather to discuss advancements in cholangiocarcinoma treatment, recent clinical research, and patient-centered care approaches. The conference will focus on the latest developments and treatment options specific to the Canadian context, providing valuable insights into the patient journey from both clinical and patient partner perspectives.

​

This event is a great opportunity to connect, learn, and share experiences with others dedicated to improving outcomes for those affected by cholangiocarcinoma.​

​​

​

Join us for this enriching event and be a part of the ongoing efforts to make a difference!

oicr_edited.jpg
bc-cancer-mention_edited.jpg
639303bb2a61e512440672_edited.jpg
  • Instagram
  • Facebook
  • Twitter
image.png
leaf-cihr-colour-en_edited.png

The Canadian Cholangiocarcinoma Collaborative (C3) is supported by a Canadian Cancer Society Breakthrough Team Grant in partnership with the Canadian Institutes of Health Research. The granting funds for C3 are managed by The Ottawa Hospital Research Institute, which serves as the lead institute for all collaborative operations.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page